Ursodeoxycholic acid (UDCA) is widely used for the treatment of chronic cholestatic liver diseases. However, a recent randomized, controlled trial has surprisingly shown that the use of high-dose ...

Effective therapy for NASH is still lacking. In this study, we investigated the effects of Ursodeoxycholic acid (UDCA) in the treatment of NASH. Methods: Western and Chinese databases were ...

Ipsen has received the UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for its Elafibranor (Iqirvo) ...

The active ingredient, ursodeoxycholic acid, is used to dissolve gallstones and treat liver disease. But there is no proof that it is effective against the coronavirus and the process is painful ...

A drug called ursodeoxycholic acid may help protect the liver. It works by improving bile flow, but it doesn’t treat cholangitis itself. The signs and symptoms of cholangitis will vary from ...

In 1902 a Swedish scientist isolated one of the chemicals in bear bile, later named ursodeoxycholic acid, and it’s now used in drugs for liver diseases and gallstones. But Iaizzo and other ...

Primary biliary cholangitis (PBC), previously referred to as primary biliary cirrhosis, is a long-term liver condition ...

For cholesterol gallstones, medications like ursodeoxycholic acid can be prescribed, although this method may take months or ...

UK MHRA grants marketing approval for Ipsen’s elafibranor to treat adults with rare liver disease known as PCB: United Kingdom Thursday, October 10, 2024, 15:00 Hrs [IST] The Me ...

(RTTNews) - Ipsen (IPSEY) announced the European Commission has conditionally approved Iqirvo 80mg tablets for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid ...

in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as a monotherapy in patients unable to tolerate UDCA. Iqirvo is a first-in-class, oral, peroxisome ...

For patients who are unable to tolerate or who refuse surgery, endoscopic biliary sphincterotomy or treatment with ursodeoxycholic acid are reasonable alternatives. Additional controlled ...